[{"AccountsPayableCurrent_0_Q1_USD":1845000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":91000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3259000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":672000.0,"OperatingIncomeLoss_1_Q1_USD":-3441000.0,"NonoperatingIncomeExpense_1_Q1_USD":-77000.0,"NetIncomeLoss_1_Q1_USD":-2812000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-7026000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":3218000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-623000.0,"LiabilitiesCurrent_0_Q1_USD":25643000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":184866000.0,"Liabilities_0_Q1_USD":48195000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":335000.0,"InvestmentIncomeNet_1_Q1_USD":26000.0,"InventoryRawMaterials_0_Q1_USD":4896000.0,"InventoryNet_0_Q1_USD":8290000.0,"InventoryFinishedGoods_0_Q1_USD":1744000.0,"InterestPaidNet_1_Q1_USD":82000.0,"InterestExpense_1_Q1_USD":136000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":35238000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":52989000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1432000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1570000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1225000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-5227000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-95000.0,"InventoryWorkInProcess_0_Q1_USD":1650000.0,"OtherAssetsNoncurrent_0_Q1_USD":4121000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-1647000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-1652000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q1_USD":3000000.0,"UndistributedEarningsOfForeignSubsidiaries_0_Q1_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":230000.0,"StockholdersEquity_0_Q1_USD":136671000.0,"ShortTermBorrowings_0_Q1_USD":10000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":9192000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":350000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":23003000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":113253000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":11663000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":4000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":29319000.0,"ProfitLoss_1_Q1_USD":-2812000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":4000000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":230000.0,"PrepaidExpenseCurrent_0_Q1_USD":2972000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7689000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":450000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.05,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":782000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":853000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-77000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":10713000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-5000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":13878000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1_Q1_USD":100000.0,"IncomeTaxesReceivable_0_Q1_USD":1916000.0,"CommonStockSharesOutstanding_0_Q1_shares":13975000.0,"CommonStockSharesIssued_0_Q1_shares":13975000.0,"CommonStockSharesAuthorized_0_Q1_shares":45000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.05,"CommitmentsAndContingencies_0_Q1_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-4503000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":26650000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":26650000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":820000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":5693000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":5693000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":5697000.0,"CommonStockValue_0_Q1_USD":699000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":4000.0,"Assets_0_Q1_USD":184866000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":1200000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":124000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1680000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1680000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":860000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":22644000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":75000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":252000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":6076000.0,"AccretionExpense_1_Q1_USD":3000.0,"AccountsReceivableNetCurrent_0_Q1_USD":8010000.0,"AssetsCurrent_0_Q1_USD":64916000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-4464000.0,"ContractWithCustomerAssetNet_0_Q1_USD":6668000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":4497000.0,"IncomeTaxesPaidNet_1_Q1_USD":3000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-3518000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-706000.0,"Goodwill_0_Q1_USD":44900000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":33000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":34658000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":3908000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":3871000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":2940000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":2684000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":3436000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":3998000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":13821000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":17751000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":13900000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3292000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":-72000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"EarningsPerShareDiluted_1_Q1_USD":-0.2,"EarningsPerShareBasic_1_Q1_USD":-0.2,"DepreciationDepletionAndAmortization_1_Q1_USD":2376000.0,"DeferredRevenueNoncurrent_0_Q1_USD":9292000.0,"DeferredRevenueCurrent_0_Q1_USD":4430000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":2547000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-640000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":6372000.0,"CostsAndExpenses_1_Q1_USD":26444000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-706000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":13878000.0,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20211231","fy":"2022.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20220204"}]